Journal article

Omalizumab: NICE to USE you, to LOSE you NICE.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Bush, A., & Pavord, I. (2013). Omalizumab: NICE to USE you, to LOSE you NICE. Thorax, 68(1), 7–8.

MLA Style

Bush, A, and I Pavord. “Omalizumab: NICE to USE You, to LOSE You NICE.” Thorax, vol. 68, no. 1, 2013, pp. 7–8.

Chicago Style

Bush, A, and I Pavord. 2013. “Omalizumab: NICE to USE You, to LOSE You NICE.” Thorax 68 (1): 7–8.
Print

Access Document

Publisher copy:: 10.1136/thoraxjnl-2012-202969

Authors

+ Bush, A More by this author

Role:: Author

+ Pavord, I More by this author

Role:: Author

Journal:: Thorax More from this journal
Volume:: 68
Issue:: 1
Pages:: 7-8
Publication date:: 2013-01-01
DOI:: 10.1136/thoraxjnl-2012-202969
EISSN:: 1468-3296
ISSN:: 0040-6376

Language:: English
Keywords:: Antibodies, Monoclonal, Humanized

Humans

Male

Female

Guideline Adherence

Risk Assessment

Adult

Age Factors

Practice Guidelines as Topic

Young Adult

Anti-Asthmatic Agents

Asthma

Antibodies, Anti-Idiotypic

Administration, Inhalation

Severity of Illness Index

Great Britain

Adolescent

Child

Treatment Outcome
Pubs id:: pubs:423833
UUID:: uuid:eb80fcad-a5e4-4f0e-a5d3-7f9166e5020d
Local pid:: pubs:423833
Source identifiers:: 423833
Deposit date:: 2013-11-16
ARK identifier:: ark:/29072/ora_eb80fcada5e44f0ea5d37f9166e5020d

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP